Villarino Alejandro V, Kanno Yuka, O'Shea John J
Molecular Immunology and Inflammation Branch, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Nat Immunol. 2017 Mar 22;18(4):374-384. doi: 10.1038/ni.3691.
Kinases of the Jak ('Janus kinase') family and transcription factors (TFs) of the STAT ('signal transducer and activator of transcription') family constitute a rapid membrane-to-nucleus signaling module that affects every aspect of the mammalian immune system. Research on this paradigmatic pathway has experienced breakneck growth in the quarter century since its discovery and has yielded a stream of basic and clinical insights that have profoundly influenced modern understanding of human health and disease, exemplified by the bench-to-bedside success of Jak inhibitors ('jakinibs') and pathway-targeting drugs. Here we review recent advances in Jak-STAT biology, focusing on immune cell function, disease etiology and therapeutic intervention, as well as broader principles of gene regulation and signal-dependent TFs.
Jak(“Janus激酶”)家族的激酶和STAT(“信号转导子和转录激活子”)家族的转录因子构成了一个快速的从细胞膜到细胞核的信号传导模块,该模块影响哺乳动物免疫系统的各个方面。自这一典型信号通路被发现以来的四分之一个世纪里,对它的研究经历了飞速发展,并产生了一系列基础和临床见解,这些见解深刻地影响了现代对人类健康和疾病的理解,Jak抑制剂(“Jakinibs”)和靶向该信号通路的药物从实验室到临床的成功就是例证。在这里,我们综述Jak-STAT生物学的最新进展,重点关注免疫细胞功能、疾病病因和治疗干预,以及基因调控和信号依赖转录因子的更广泛原则。